These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 20814819

  • 21. Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer.
    Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, Bhargava R.
    Oncology; 2011; 80(5-6):341-9. PubMed ID: 21791944
    [Abstract] [Full Text] [Related]

  • 22. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
    Yang Q, Chen J, Li HJ, Yu M, Tian CX, Lü Q.
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
    [Abstract] [Full Text] [Related]

  • 23. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J, Polgár C, Major T, Németh G.
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [Abstract] [Full Text] [Related]

  • 24. T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy.
    Kaplan HG, Malmgren JA, Atwood M.
    Breast J; 2009 Mar; 15(5):454-60. PubMed ID: 19671105
    [Abstract] [Full Text] [Related]

  • 25. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y, Guan Y, Zhao WH, Li Q, Xu BH.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [Abstract] [Full Text] [Related]

  • 26. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK, Graham PH, O'Toole SA, McNeil CM, Browne L, Morey AL, Eggleton S, Beretov J, Theocharous C, Capp A, Nasser E, Kearsley JH, Delaney G, Papadatos G, Fox C, Sutherland RL.
    J Clin Oncol; 2009 Oct 01; 27(28):4701-8. PubMed ID: 19720911
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Breast cancer in very young women.
    Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J.
    Eur J Surg Oncol; 2011 Dec 01; 37(12):1030-7. PubMed ID: 21937191
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.
    Wo JY, Taghian AG, Nguyen PL, Raad RA, Sreedhara M, Bellon JR, Wong JS, Gadd MA, Smith BL, Harris JR.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):188-96. PubMed ID: 20171798
    [Abstract] [Full Text] [Related]

  • 32. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT, Yong CM, Abnousi F, Lee J, Kader HA, Hayashi A, Olivotto IA.
    J Am Coll Surg; 2005 Jun 01; 200(6):912-21. PubMed ID: 15922205
    [Abstract] [Full Text] [Related]

  • 33. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
    Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K.
    J BUON; 2013 Jun 01; 18(2):335-41. PubMed ID: 23818343
    [Abstract] [Full Text] [Related]

  • 34. [Clinical characteristics and prognosis of different subtypes of breast cancer].
    Yuan ZY, Wang SS, Zhu MQ, Zheng L, Luo WB, Zhou ZM, Guan ZZ.
    Zhonghua Zhong Liu Za Zhi; 2008 Jun 01; 30(6):456-61. PubMed ID: 19024523
    [Abstract] [Full Text] [Related]

  • 35. Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.
    Van Belle V, Van Calster B, Brouckaert O, Vanden Bempt I, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, Van Huffel S, Neven P.
    J Clin Oncol; 2010 Sep 20; 28(27):4129-34. PubMed ID: 20713855
    [Abstract] [Full Text] [Related]

  • 36. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):357-64. PubMed ID: 18676091
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Locoregional failure in early-stage breast cancer patients treated with radical mastectomy and adjuvant systemic therapy: which patients benefit from postmastectomy irradiation?
    Trovo M, Durofil E, Polesel J, Roncadin M, Perin T, Mileto M, Piccoli E, Quitadamo D, Massarut S, Carbone A, Trovo MG.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):e153-7. PubMed ID: 22386375
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.